MX2012013387A - Nuevos procesos. - Google Patents

Nuevos procesos.

Info

Publication number
MX2012013387A
MX2012013387A MX2012013387A MX2012013387A MX2012013387A MX 2012013387 A MX2012013387 A MX 2012013387A MX 2012013387 A MX2012013387 A MX 2012013387A MX 2012013387 A MX2012013387 A MX 2012013387A MX 2012013387 A MX2012013387 A MX 2012013387A
Authority
MX
Mexico
Prior art keywords
novel processes
formula
atherosclerosis
intermediates
compounds
Prior art date
Application number
MX2012013387A
Other languages
English (en)
Inventor
Claire Frances Crawford
Kevin Stuart Cardwell
Suzanne Helen Davies
Charles Edward Wade
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44992024&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012013387(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX2012013387A publication Critical patent/MX2012013387A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C229/48—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms of the same non-condensed ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Esta invención se refiere a métodos para preparar un compuesto de fórmula (I) y a intermedios para ello (Ver Formula) siendo los compuestos de fórmula (I) útiles para tratar enfermedades cardiovasculares e inflamatorias tales como aterosclerosis.
MX2012013387A 2010-05-17 2011-05-17 Nuevos procesos. MX2012013387A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34522410P 2010-05-17 2010-05-17
PCT/US2011/036821 WO2011146494A1 (en) 2010-05-17 2011-05-17 Novel processes

Publications (1)

Publication Number Publication Date
MX2012013387A true MX2012013387A (es) 2012-12-10

Family

ID=44992024

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013387A MX2012013387A (es) 2010-05-17 2011-05-17 Nuevos procesos.

Country Status (24)

Country Link
US (2) US9447052B2 (es)
EP (1) EP2571857B1 (es)
JP (1) JP6027529B2 (es)
KR (1) KR20130089157A (es)
CN (2) CN103003249B (es)
AR (1) AR081399A1 (es)
AU (1) AU2011256270B2 (es)
BR (1) BR112012030532A2 (es)
CA (1) CA2799520C (es)
CL (1) CL2012003206A1 (es)
CO (1) CO6630197A2 (es)
CR (1) CR20120630A (es)
DO (1) DOP2012000289A (es)
EA (1) EA026569B1 (es)
IL (1) IL223068A0 (es)
MA (1) MA34301B1 (es)
MX (1) MX2012013387A (es)
NZ (1) NZ603672A (es)
PE (1) PE20130318A1 (es)
SG (1) SG185559A1 (es)
TW (1) TW201209043A (es)
UY (1) UY33388A (es)
WO (1) WO2011146494A1 (es)
ZA (1) ZA201208631B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201209043A (en) * 2010-05-17 2012-03-01 Glaxo Group Ltd Novel processes
WO2015087239A1 (en) 2013-12-11 2015-06-18 Ranbaxy Laboratories Limited Processes for the preparation of darapladib and its intermediates
WO2015092687A2 (en) 2013-12-17 2015-06-25 Ranbaxy Laboratories Limited Process for the purification of darapladib
WO2019063634A1 (en) 2017-09-26 2019-04-04 INSERM (Institut National de la Santé et de la Recherche Médicale) DARAPLADIB RADIOMARQUÉ, ITS ANALOGUES AND THEIR USE AS IMAGING COMPOUNDS
US10866963B2 (en) * 2017-12-28 2020-12-15 Dropbox, Inc. File system authentication

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1143516B (de) 1961-04-27 1963-02-14 Bayer Ag Verfahren zur Herstellung von Peptiden
US4277465A (en) 1978-08-26 1981-07-07 Kyoto Yakuhin Kogyo Kabushiki Kaisha Adjuvant for promoting absorption of therapeutically active substances through the digestive tract
US4235776A (en) * 1979-03-15 1980-11-25 Eli Lilly And Company Tetrahydro-2H-benzo[c]pyrroles
DE2941597A1 (de) * 1979-10-13 1981-04-23 Basf Ag, 6700 Ludwigshafen Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
US4619941A (en) * 1984-11-19 1986-10-28 American Cyanamid Company N-[(1H-imidazol-1-yl)alkyl]-1H-indolecarboxamides useful as thromboxane synthetase inhibitors and antihypertensive agents
JP2001522844A (ja) * 1997-11-06 2001-11-20 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ピリミジノン化合物およびそれを含有する医薬組成物
US6750228B1 (en) 1997-11-14 2004-06-15 Pharmacia Corporation Aromatic sulfone hydroxamic acid metalloprotease inhibitor
AU1520300A (en) 1998-11-05 2000-05-29 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
BR0010220A (pt) * 1999-05-01 2002-05-14 Smithkline Beecham Plc Compostos de pirimidinona
WO2001060805A1 (en) * 2000-02-16 2001-08-23 Smithkline Beecham P.L.C. Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
GB0119795D0 (en) * 2001-08-14 2001-10-03 Smithkline Beecham Plc Novel process
TW201209043A (en) * 2010-05-17 2012-03-01 Glaxo Group Ltd Novel processes

Also Published As

Publication number Publication date
WO2011146494A1 (en) 2011-11-24
AU2011256270B2 (en) 2015-11-26
AU2011256270A1 (en) 2012-12-20
US9725420B2 (en) 2017-08-08
KR20130089157A (ko) 2013-08-09
US20130060028A1 (en) 2013-03-07
CA2799520A1 (en) 2011-11-24
EP2571857B1 (en) 2017-08-23
NZ603672A (en) 2015-01-30
EA201291235A1 (ru) 2013-04-30
PE20130318A1 (es) 2013-04-11
ZA201208631B (en) 2013-09-25
UY33388A (es) 2011-12-01
CA2799520C (en) 2016-09-13
CR20120630A (es) 2013-02-15
MA34301B1 (fr) 2013-06-01
EP2571857A1 (en) 2013-03-27
EP2571857A4 (en) 2013-11-20
TW201209043A (en) 2012-03-01
CN103003249A (zh) 2013-03-27
IL223068A0 (en) 2013-02-03
CL2012003206A1 (es) 2013-01-25
US20160347720A1 (en) 2016-12-01
EA026569B1 (ru) 2017-04-28
DOP2012000289A (es) 2013-04-15
JP2013530948A (ja) 2013-08-01
SG185559A1 (en) 2012-12-28
CN105837520A (zh) 2016-08-10
AR081399A1 (es) 2012-08-29
JP6027529B2 (ja) 2016-11-16
CN103003249B (zh) 2016-04-27
US9447052B2 (en) 2016-09-20
BR112012030532A2 (pt) 2015-09-29
CO6630197A2 (es) 2013-03-01

Similar Documents

Publication Publication Date Title
UA110338C2 (en) Chemical compounds
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
MA32551B1 (fr) Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires
CL2009000503A1 (es) Proceso de preparacion de compuestos derivados de acido 2-amino-5-cianobenzoico-3-sustituidos o 1h-pirazol-5-carboxamida.
SG158829A1 (en) New process for the synthesis of agomelatine
PH12015500008B1 (en) Dimethyl-benzoic acid compounds
TW201206878A (en) A method of producing ingenol-3-angelate
JO2818B1 (en) A new process for the installation of agililatine
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
WO2012061754A3 (en) Compounds and methods for treating autoimmune diseases
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
WO2011157390A3 (en) Process for the preparation of substituted 3-(1-amino-2-methylpentane-3-yl)phenyl compounds
EP2571857A4 (en) NEW PROCESSES
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
IN2014DN00144A (es)
IN2014MN00850A (es)
JO2821B1 (en) A new process for the installation of agililatine
MX2016007186A (es) Nuevo procedimiento de sintesis de la agomelatina.
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
MX337610B (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
JO3200B1 (ar) طريقة ونواتج وسيطة لتحضير أجوميلاتين
MX352295B (es) Compuestos de fenilo sustituidos.
MX2014002630A (es) Produccion de alcaloides sin el aislamiento de compuestos intermediarios.
WO2012010651A3 (en) Method for the preparation of omega-amino-alkaneamides and omega-amino-alkanethioamides as well as intermediates of this method
JO3085B1 (ar) طريقة جديدة لتصنيع أجوميلاتين